Article Details
Retrieved on: 2024-05-01 17:20:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Continuous ofatumumab treatment for up to 6 years led to a sustained low annualized relapse rate in treatment-naïve patients with relapsing MS.
Article found on: www.neurologyadvisor.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here